Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972934

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1972934

Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Insights, Competitive Landscape, and Market Forecast - 2033

PUBLISHED:
PAGES: 197 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Poly (Lactic-Co-Glycolic Acid) (PLGA) market is witnessing robust growth, fueled by increasing applications in drug delivery, medical implants, and tissue engineering. Recognized for its biodegradability, biocompatibility, and versatility, PLGA is a preferred material in both the pharmaceutical and biomedical sectors. The market is expected to grow from $1.3 billion in 2026 to $3.3 billion by 2033, at a CAGR of 14.20%. Rising healthcare expenditure, advances in polymer technology, and the growing preference for sustainable and patient-friendly solutions are shaping the market dynamics.

Market Insights

PLGA's ability to degrade into lactic and glycolic acids makes it a highly sustainable polymer for various medical applications. Its flexibility in composition, such as PLGA 50:50, 65:35, and 75:25, allows precise control over degradation rates, making it ideal for controlled drug release systems and biodegradable implants. Technological innovations, including electrospinning, 3D printing, and microsphere formulation, have further expanded its applications in advanced drug delivery and regenerative medicine.

Increasing research in nanotechnology-based drug delivery systems and targeted therapy is also contributing to market expansion. Regulatory approvals from major agencies like the FDA and EMA have further strengthened confidence in PLGA-based products, particularly in North America and Europe.

Market Drivers

Several key factors are driving the growth of the PLGA market:

  • 1. Growing Demand for Controlled Drug Delivery Systems - PLGA is widely used in sustained-release formulations, improving therapeutic outcomes and patient compliance. With the rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and diabetes, demand for such drug delivery systems is increasing rapidly.
  • 2. Expansion of the Biomedical and Medical Devices Sector - PLGA is increasingly utilized in surgical implants, fracture fixation devices, and tissue scaffolds. The global shift towards advanced medical treatments and minimally invasive procedures is boosting its adoption.
  • 3. Focus on Biodegradable and Eco-Friendly Polymers - PLGA's biodegradable nature reduces environmental impact compared to conventional polymers. As healthcare providers and manufacturers adopt more sustainable materials, PLGA is becoming a preferred choice for medical, cosmetic, and pharmaceutical applications.
  • 4. Technological Advancements in Polymer Development - Innovations in molecular weight optimization, copolymer ratios, and fabrication techniques are enhancing PLGA's performance, mechanical strength, and drug encapsulation efficiency. These improvements are enabling its use in more complex and high-value applications.

Business Opportunities

The growing PLGA market presents significant opportunities for pharmaceutical and medical device companies. There is strong potential for the development of novel drug delivery systems, biodegradable implants, and advanced regenerative therapies. Cosmetic and dermatology applications, such as anti-aging and wound-healing formulations, also offer avenues for expansion.

Research-driven startups and companies can focus on nanoparticle-based therapies, targeted cancer treatments, and personalized medicine. Collaborations with hospitals, universities, and pharmaceutical firms can accelerate product innovation and market entry.

Regional Analysis

The PLGA market exhibits diverse regional trends:

  • North America leads the market, driven by advanced healthcare infrastructure, widespread adoption of innovative drug delivery systems, and a supportive regulatory environment.
  • Europe is witnessing significant growth due to increased research funding, a strong medical device sector, and rising demand for biodegradable polymers.
  • Asia Pacific is expected to be the fastest-growing region, fueled by expanding pharmaceutical manufacturing, rising healthcare expenditures, and increasing use of PLGA in cosmetic and dermatological applications.
  • Latin America shows gradual growth, with adoption primarily in medical implants and drug delivery systems, supported by expanding healthcare access.
  • Middle East & Africa presents emerging opportunities, with growth driven by private healthcare investment and rising chronic disease prevalence.

Key Players

The PLGA market is highly competitive, with major players focusing on product innovation, strategic partnerships, and geographic expansion:

  • Evonik Industries
  • Polysciences, Inc.
  • DSM
  • Mitsui Chemicals
  • Ashland Inc.
  • Creative PEGWorks
  • Corbion
  • Poly-Med Incorporated
  • Haihang Industry
  • Foster Corporation
  • Nomisma Healthcare Pvt. Ltd.
  • Nanosoft Polymers
  • BMG Inc.
  • Specific Polymers

These companies are actively engaging in research and development, collaborations, and acquisitions to expand their product portfolios and strengthen market presence.

Market Segmentation

By Composition

  • PLGA 50:50
  • PLGA 55:45
  • PLGA 65:35
  • PLGA 75:25
  • PLGA 85:15

By Application

  • Medical Implants
  • Drug Delivery
  • Fracture Fixation
  • Dentistry
  • Cosmetics and Dermatology
  • Miscellaneous

By Geographic Coverage

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2026
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Five Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2033
    • 2.9.2. Price Impact Factors

3. Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 3.1. Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 3.1.1. PLGA 50:50
    • 3.1.2. PLGA 55:45
    • 3.1.3. PLGA 65:35
    • 3.1.4. PLGA 75:25
    • 3.1.5. PLGA 85:15
  • 3.2. Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 3.2.1. Medical Implants
    • 3.2.2. Drug Delivery
    • 3.2.3. Fracture Fixation
    • 3.2.4. Dentistry
    • 3.2.5. Cosmetics and Dermatology
    • 3.2.6. Miscellaneous
  • 3.3. Global Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Region, Value (US$ Bn), 2020-2033
    • 3.3.1. North America
    • 3.3.2. Europe
    • 3.3.3. Asia Pacific
    • 3.3.4. Latin America
    • 3.3.5. Middle East & Africa

4. North America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 4.1. North America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 4.1.1. PLGA 50:50
    • 4.1.2. PLGA 55:45
    • 4.1.3. PLGA 65:35
    • 4.1.4. PLGA 75:25
    • 4.1.5. PLGA 85:15
  • 4.2. North America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 4.2.1. Medical Implants
    • 4.2.2. Drug Delivery
    • 4.2.3. Fracture Fixation
    • 4.2.4. Dentistry
    • 4.2.5. Cosmetics and Dermatology
    • 4.2.6. Miscellaneous
  • 4.3. North America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 4.3.1. U.S. Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 4.3.2. U.S. Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 4.3.3. Canada Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 4.3.4. Canada Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
  • 4.4. BPS Analysis/Market Attractiveness Analysis

5. Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 5.1. Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 5.1.1. PLGA 50:50
    • 5.1.2. PLGA 55:45
    • 5.1.3. PLGA 65:35
    • 5.1.4. PLGA 75:25
    • 5.1.5. PLGA 85:15
  • 5.2. Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 5.2.1. Medical Implants
    • 5.2.2. Drug Delivery
    • 5.2.3. Fracture Fixation
    • 5.2.4. Dentistry
    • 5.2.5. Cosmetics and Dermatology
    • 5.2.6. Miscellaneous
  • 5.3. Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 5.3.1. Germany Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.2. Germany Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.3. Italy Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.4. Italy Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.5. France Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.6. France Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.7. U.K. Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.8. U.K. Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.9. Spain Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.10. Spain Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.11. Russia Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.12. Russia Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 5.3.13. Rest of Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 5.3.14. Rest of Europe Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
  • 5.4. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 6.1. Asia Pacific Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 6.1.1. PLGA 50:50
    • 6.1.2. PLGA 55:45
    • 6.1.3. PLGA 65:35
    • 6.1.4. PLGA 75:25
    • 6.1.5. PLGA 85:15
  • 6.2. Asia Pacific Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 6.2.1. Medical Implants
    • 6.2.2. Drug Delivery
    • 6.2.3. Fracture Fixation
    • 6.2.4. Dentistry
    • 6.2.5. Cosmetics and Dermatology
    • 6.2.6. Miscellaneous
  • 6.3. Asia Pacific Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 6.3.1. China Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.2. China Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 6.3.3. Japan Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.4. Japan Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 6.3.5. South Korea Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.6. South Korea Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 6.3.7. India Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.8. India Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 6.3.9. Southeast Asia Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.10. Southeast Asia Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 6.3.11. Rest of SAO Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 6.3.12. Rest of SAO Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
  • 6.4. BPS Analysis/Market Attractiveness Analysis

7. Latin America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 7.1. Latin America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 7.1.1. PLGA 50:50
    • 7.1.2. PLGA 55:45
    • 7.1.3. PLGA 65:35
    • 7.1.4. PLGA 75:25
    • 7.1.5. PLGA 85:15
  • 7.2. Latin America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 7.2.1. Medical Implants
    • 7.2.2. Drug Delivery
    • 7.2.3. Fracture Fixation
    • 7.2.4. Dentistry
    • 7.2.5. Cosmetics and Dermatology
    • 7.2.6. Miscellaneous
  • 7.3. Latin America Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 7.3.1. Brazil Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 7.3.2. Brazil Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 7.3.3. Mexico Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 7.3.4. Mexico Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 7.3.5. Argentina Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 7.3.6. Argentina Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 7.3.7. Rest of LATAM Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 7.3.8. Rest of LATAM Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
  • 7.4. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, 2020-2033

  • 8.1. Middle East & Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, Value (US$ Bn), 2020-2033
    • 8.1.1. PLGA 50:50
    • 8.1.2. PLGA 55:45
    • 8.1.3. PLGA 65:35
    • 8.1.4. PLGA 75:25
    • 8.1.5. PLGA 85:15
  • 8.2. Middle East & Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, Value (US$ Bn), 2020-2033
    • 8.2.1. Medical Implants
    • 8.2.2. Drug Delivery
    • 8.2.3. Fracture Fixation
    • 8.2.4. Dentistry
    • 8.2.5. Cosmetics and Dermatology
    • 8.2.6. Miscellaneous
  • 8.3. Middle East & Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Country, Value (US$ Bn), 2020-2033
    • 8.3.1. GCC Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 8.3.2. GCC Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 8.3.3. South Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 8.3.4. South Africa Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 8.3.5. Egypt Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 8.3.6. Egypt Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 8.3.7. Nigeria Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 8.3.8. Nigeria Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
    • 8.3.9. Rest of Middle East Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Composition, 2020-2033
    • 8.3.10. Rest of Middle East Poly (Lactic-Co-Glycolic Acid) (PLGA) Market Outlook, by Application, 2020-2033
  • 8.4. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Evonik Industries
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Polysciences, Inc.
    • 9.4.3. DSM
    • 9.4.4. Mitsui Chemicals
    • 9.4.5. Ashland Inc.
    • 9.4.6. Creative PEGWorks
    • 9.4.7. Corbion
    • 9.4.8. Poly-Med Incorporated
    • 9.4.9. Haihang Industry
    • 9.4.10. Foster Corporation

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!